Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin J Shattock

Showing results (11-20 of 210) with videos related to

Pageof 21
Sort By:
Retrovirology|October 13, 2010
Innate immunity against HIV: a priority target for HIV prevention researchPersephone Borrow, Robin J Shattock, Annapurna Vyakarnam, et al.
Virology|July 31, 2007
High-mannose-specific deglycosylation of HIV-1 gp120 induced by resistance to cyanovirin-N and the impact on antibody neutralizationQinxue Hu, Naheed Mahmood, Robin J Shattock
AIDS (London, England)|June 6, 2008
Vaginal microbicides: the importance of effective distribution, retention and coating of the mucosaJanneke van de Wijgert, Robin J Shattock
The Journal of General Virology|September 3, 2010
C-C chemokine receptor type 5 (CCR5) utilization of transmitted and early founder human immunodeficiency virus type 1 envelopes and sensitivity to small-molecule CCR5 inhibitorsQinxue Hu, Xin Huang, Robin J Shattock
Expert Opinion on Biological Therapy|April 19, 2005
Therapeutic role of CD8+ T cells in HIV-1 infection: targets and suppressors of viral replicationL R Meireles-de-Souza, Robin J Shattock
AIDS (London, England)|November 21, 2007
Vaginal microbicides: moving ahead after an unexpected setbackJanneke Hhm van de Wijgert, Robin J Shattock
Lancet (London, England)|July 4, 2021
Learning from crisis: building resilient systems to combat future pandemicsIlona Kickbusch, Gabriel M Leung, Robin J Shattock
Vaccine|January 13, 2010
Vaccine adjuvants: a priority for vaccine researchAli M Harandi, Donata Medaglini, Robin J Shattock, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 22, 2020
Use of Chlamydial Elementary Bodies as Probes to Isolate Pathogen-Specific Human Monoclonal AntibodiesChristopher L Pinder, Paul F McKay, Robin J Shattock
Journal of Translational Medicine|February 3, 2011
Selective transmission of R5 HIV-1 variants: where is the gatekeeper?Jean-Charles Grivel, Robin J Shattock, Leonid B Margolis
Pageof 21

Showing results (11-20 of 210) with videos related to

Sort By:
Pageof 21
Retrovirology|October 13, 2010
Innate immunity against HIV: a priority target for HIV prevention researchPersephone Borrow, Robin J Shattock, Annapurna Vyakarnam, et al.
Virology|July 31, 2007
High-mannose-specific deglycosylation of HIV-1 gp120 induced by resistance to cyanovirin-N and the impact on antibody neutralizationQinxue Hu, Naheed Mahmood, Robin J Shattock
AIDS (London, England)|June 6, 2008
Vaginal microbicides: the importance of effective distribution, retention and coating of the mucosaJanneke van de Wijgert, Robin J Shattock
The Journal of General Virology|September 3, 2010
C-C chemokine receptor type 5 (CCR5) utilization of transmitted and early founder human immunodeficiency virus type 1 envelopes and sensitivity to small-molecule CCR5 inhibitorsQinxue Hu, Xin Huang, Robin J Shattock
Expert Opinion on Biological Therapy|April 19, 2005
Therapeutic role of CD8+ T cells in HIV-1 infection: targets and suppressors of viral replicationL R Meireles-de-Souza, Robin J Shattock
AIDS (London, England)|November 21, 2007
Vaginal microbicides: moving ahead after an unexpected setbackJanneke Hhm van de Wijgert, Robin J Shattock
Lancet (London, England)|July 4, 2021
Learning from crisis: building resilient systems to combat future pandemicsIlona Kickbusch, Gabriel M Leung, Robin J Shattock
Vaccine|January 13, 2010
Vaccine adjuvants: a priority for vaccine researchAli M Harandi, Donata Medaglini, Robin J Shattock, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 22, 2020
Use of Chlamydial Elementary Bodies as Probes to Isolate Pathogen-Specific Human Monoclonal AntibodiesChristopher L Pinder, Paul F McKay, Robin J Shattock
Journal of Translational Medicine|February 3, 2011
Selective transmission of R5 HIV-1 variants: where is the gatekeeper?Jean-Charles Grivel, Robin J Shattock, Leonid B Margolis
Pageof 21